This year’s Health for Humanity Report is a story of transformative innovation on every front of healthcare. I’m immensely proud of the sheer breadth of our work—and your commitment to taking on the world’s most complex, urgent challenges.
Click here to read more.
Posted on: 06/29/2021
Today, Time chose Johnson & Johnson for inclusion on its first-ever list of TIME100 Most Influential Companies. An extension of the publication’s annual TIME100 list of the world’s most influential people, the new list singles out 100 companies that are positively impacting the world. Click here to learn more.
Publish Date: 04/28/2021
NEW BRUNSWICK, N.J., April 13, 2021– The safety and well-being of the people who use our products is our number one priority. We are aware of an extremely rare disorder involving people with blood clots in combination with low platelets in a small number of individuals who have received our COVID-19 vaccine.
Click here to learn more.
Publish Date: 04/14/2021
the U.S. Food and Drug Administration (FDA) granted Emergency Use Authorization
for our company’s investigational COVID-19 vaccine—marking the culmination of a
year of extraordinary innovation and collaboration by the people of Johnson
Click here to learn more.
Posted on 03/01/2021
Today Johnson & Johnson announced positive topline Phase 3 clinical trial results for our single-dose COVID-19 vaccine candidate. I sent the following message to our company’s 135,000 employees, and wanted to share it with the wider community. I hope this news serves as a welcome reminder of the transformative power of science—and the possibility of a better, healthier future.
Click here to read Alex's announcement.
Click here for eligibility and access information.
Updated on 02/01/2021
The company is proud to have placed in the top 20 on the prestigious list for its commitment to innovation, dedication to social responsibility and the quality of its products among other noteworthy attributes - all in the face of a global pandemic.
Click here to read the article.
Posted on 02/01/2021
Eligible individuals 65+ with an iPhone who are covered by Medicare Advantage plans can now enroll in the Heartline™ Study.
Heartline is a virtual research study designed to explore how everyday technology like the iPhone and Apple Watch can enable earlier detection of atrial fibrillation, a leading cause of stroke. Previously, the study was only open to eligible individuals with Original (Traditional) Medicare.
Participating in the Heartline Study is one way you can partake in heart health education and activities that may help improve your sleep, fitness and wellness - all from the comfort of your home.
Click here to learn more.
Posted on: 10/12/2020
We are continually evaluating the Johnson & Johnson Savings Plan investment options to ensure we are providing a diverse set of choices that can help you meet your financial and retirement goals by not placing too much of your retirement savings in any one company or industry. Starting September 1, 2020, we are implementing a new 20% investment limit on the amount that participants may allocate in the Johnson & Johnson Common Stock Fund within the Savings Plan. Click here to learn more.
Posted on: 7/6/2020
Together we can make a difference. In response to the COVID-19 pandemic, Johnson & Johnson is donating $1 million to two organizations—COVID-19 Solidarity Response Fund and the CDC Foundation’s ALL OF US Campaign—making employee and retiree donations go further by matching individual contributions to each organization dollar to dollar up to $1 million. Donate now.
As a way to offer the best care possible in light of the COVID-19 pandemic, UnitedHealthcare is offering their HouseCalls Program in a virtual setting. Members who have an email and webcam capability may participate in a virtual nurse HouseCall visit. If you were scheduled for a HouseCall visit at home, a Scheduling Coordinator will reach out to you by phone to offer a virtual visit. If you have questions, please contact UnitedHealthcare at the number on the back of your member ID card.
Click here for guidance from UHC on what you need to know about The Novel Coronavirus.
In celebration of the Year of the Nurse and Midwife, Johnson & Johnson and the American Nurses Association are pleased to launch SEE YOU NOW, an inspiring external podcast series that spotlights nurses who are driving innovative solutions for today's most challenging healthcare problems.Subscribe today wherever you find your podcasts and join in the online conversation at #SeeYouNow.
Your New Retirement Investment OptionsLast September 30, 2019, nine new custom target date fund investment options (also known as the Target Retirement Funds) were introduced to the Johnson & Johnson Savings Plan. With the launch of the custom target date funds, the Balanced Fund was eliminated. Any amounts invested in the Balanced Fund on September 27, 2019, were automatically transferred to the Target Retirement Fund that most closely aligns with the year the participant will reach age 62. As always, how you invest your money is up to you.Click here for a letter that covers important details. We have also created a brochure to help you make informed decisions about your new investment options. Additional information is available on the For Your Benefit (FYB) website.
Turn over a new leaf with your voluntary benefits from Added Benefits®. As a retiree of Johnson & Johnson, you could enjoy special savings not available to the general public on reliable coverage for your automobiles, home1, personal property, and pets. Plus, you can access special discounts at your favorite retailers.
Call 1-888-332-4134 or visit www.AddedBenefitsJJ.com to participate.
Dear Johnson & Johnson Retiree,
The J&J North America Government Affairs department is pleased to announce a new grassroots advocacy website designed for employees and retirees. The Johnson & Johnson Political Information Network JJPIN site is your one-stop resource for the company’s current federal and state legislative priorities, your legislators and nonpartisan voting information. Also, as appropriate, you may be asked to voluntarily weigh in with your elected representative about an important piece of legislation with significant impact to our business. Please take a moment to visit the site at: www.jjpin.com. Registration is as easy as signing onto the online company store. Your voice makes a difference. Thank you.
This website is solely for retirees of the Johnson & Johnson Family of Companies, and will help you reconnect with colleagues, stay up to date on the latest Johnson & Johnson news, and take advantage of everything available to you as a retiree.
For over 125 years, the employees of the Johnson & Johnson Family of Companies have worked to advance the health and well-being of people throughout the world. Thank you for your contributions in pursuit of this goal.
Engage with your health and well-being and participate in these weekly US Health & Well-being Webinars (H&Webinars) to stay active. No equipment needed, just set up your mat or towel, water, and appropriate footwear based on type of class. Please note: Group Exercise classes are intended for US Johnson & Johnson employees, contractors and retirees only and begin promptly at the time listed. Log on 5 minutes early for registration and safety guidelines.
Click here to view the schedule.
We recommend pre-registration (using the appropriate link) for the individual class/date you plan to attend. Once registered, download the calendar invite from the confirmation email. After adding that class to your calendar, make that class a reoccurrence through the end of the month.
To access your benefits information, click here to visit the For Your Benefit (FYB) website (Use the Chrome, Edge, or Firefox browsers for an optimal experience).
Benefit Service Center: 1-800-565-0122
Click Here for COVID-19 updates from Johnson & Johnson benefit service administrators.
NYSE : JNJ
Your Equity Awards
ARAG Legal Insurance Plan